Schedule 13G ownership disclosure

Clearmind Medicine Inc.

Security class unavailable · CUSIP: 850532047

Event date: 2024-01-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
125,000
Percent of class
7.5100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-24-000267
Form type
SC 13G
Filer
Clearmind Medicine Inc.
CIK
CIK 1892500
Filed
Jan 22, 2024
Reporting period
Jan 11, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub